Abstract:Postzygotic single-nucleotide mosaicisms (pSNMs) have been extensively studied in tumors and are known to play critical roles in tumorigenesis. However, the patterns and origin of pSNMs in normal organs of healthy humans remain largely unknown. Using whole-genome sequencing and ultra-deep amplicon re-sequencing, we identified and validated 164 pSNMs from 27 postmortem organ samples obtained from five healthy donors. The mutant allele fractions ranged from 1.0% to 29.7%. Inter- and intra-organ comparison revealed two distinctive types of pSNMs, with about half originating during early embryogenesis (embryonic pSNMs) and the remaining more likely to result from clonal expansion events that had occurred more recently (clonal expansion pSNMs). Compared to clonal expansion pSNMs, embryonic pSNMs had higher proportion of C>T mutations with elevated mutation rate at CpG sites. We observed differences in replication timing between these two types of pSNMs, with embryonic and clonal expansion pSNMs enriched in early- and late-replicating regions, respectively. An increased number of embryonic pSNMs were located in open chromatin states and topologically associating domains that transcribed embryonically. Our findings provide new insights into the origin and spatial distribution of postzygotic mosaicism during normal human development. Author Summary Genomic mosaicism led by postzygotic mutation is the major cause of cancers and many non-cancer developmental disorders. Theoretically, postzygotic mutations should be accumulated during the developmental process of healthy individuals, but the genome-wide characterization of postzygotic mosaicisms across many organ types of the same individual remained limited. In this study, we identified and validated two types of postzygotic mosaicism from the whole-genomes of 27 organs obtained from five healthy donors. We further found that the postzygotic mosaicisms arising during early embryogenesis and later clonal expansion events show distinct genomic patterns in mutation spectrum, replication timing, and chromatin status.

Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations.

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

Autism risk in offspring can be assessed through quantification of male sperm mosaicism

Genome-wide characteristics of de novo mutations in autism

Somatic Mosaicism and Autism Spectrum Disorder

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Noncoding de novo mutations in are associated with autism spectrum disorders

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Rates of contributory de novo mutation in high and low-risk autism families

Genomic Patterns of De Novo Mutation in Simplex Autism

Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families

Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of “ De Novo ” SCN1A Mutations in Children with Dravet Syndrome

The contribution of de novo coding mutations to autism spectrum disorder

Parental Mosaicism in De Novo Neurodevelopmental Diseases

Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation

Distinctive types of postzygotic single-nucleotide mosaicisms in healthy individuals revealed by genome-wide profiling of multiple organs

De novo genic mutations among a Chinese autism spectrum disorder cohort

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

Genome-wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes.